Comparison of Immulite with Vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands
F Vlaspolder, P Singer, A Smit… - Clinical Diagnostic …, 2001 - Am Soc Microbiol
F Vlaspolder, P Singer, A Smit, RJA Diepersloot
Clinical Diagnostic Laboratory Immunology, 2001•Am Soc MicrobiolABSTRACT A comparative evaluation of the Vidas system (bioMérieux, Marcy l'Etoile,
France) and the Immulite System (Diagnostic Products Corporation) was performed using
500 prospectively collected serum samples. As part of a routine antenatal screening
program, these samples were tested for hepatitis B surface antigen, and immunoglobulin G
(IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement
between the two assay systems ranged from 98.0 to 99.8%. After discrepancy analysis the …
France) and the Immulite System (Diagnostic Products Corporation) was performed using
500 prospectively collected serum samples. As part of a routine antenatal screening
program, these samples were tested for hepatitis B surface antigen, and immunoglobulin G
(IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement
between the two assay systems ranged from 98.0 to 99.8%. After discrepancy analysis the …
Abstract
A comparative evaluation of the Vidas system (bioMérieux, Marcy l'Etoile, France) and the Immulite System (Diagnostic Products Corporation) was performed using 500 prospectively collected serum samples. As part of a routine antenatal screening program, these samples were tested for hepatitis B surface antigen, and immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement between the two assay systems ranged from 98.0 to 99.8%. After discrepancy analysis the outcome in terms of relative sensitivity and specificity varied from 97.5 to 100%.
American Society for Microbiology